TABLE OF CONTENTS
Volume 28, Issue 11 (November 2003)
Original Articles
SSR181507, A Dopamine D2 Receptor Antagonist and 5-HT1A Receptor Agonist. II: Behavioral Profile Predictive of an Atypical Antipsychotic Activity FREE
Ronan Depoortere, Denis Boulay, Ghislaine Perrault, Olivier Bergis, Michel Decobert, Dominique Françon, Mireille Jung, Jacques Simiand, Philippe Soubrié and Bernard Scatton
Neuropsychopharmacology 28: 1889-1902; advance online publication, August 6, 2003; doi:10.1038/sj.npp.1300261
Effects of a Dopamine D3 Receptor Ligand, BP 897, on Acquisition and Expression of Food-, Morphine-, and Cocaine-induced Conditioned Place Preference, and Food-seeking Behavior in Rats FREE
Christine Duarte, Cécil Lefebvre, Frédérique Chaperon, Michel Hamon and Marie-Hélène Thiébot
Neuropsychopharmacology 28: 1903-1915; advance online publication, August 13, 2003; doi:10.1038/sj.npp.1300276
How Does the Benzamide Antipsychotic Amisulpride get into the Brain?—An In Vitro Approach Comparing Amisulpride with Clozapine FREE
Sebastian Härtter, Sabine Hüwel, Tina Lohmann, Amal Abou el ela, Peter Langguth, Christoph Hiemke and Hans-Joachim Galla
Neuropsychopharmacology 28: 1916-1922; advance online publication, July 9, 2003; doi:10.1038/sj.npp.1300244
AMPA Receptor Stimulation within the Central Nucleus of the Amygdala Elicits a Differential Activation of Central Dopaminergic Systems FREE
Thomas A Stalnaker and Craig W Berridge
Neuropsychopharmacology 28: 1923-1934; advance online publication, August 13, 2003; doi:10.1038/sj.npp.1300268
Short-Term Adolescent Nicotine Exposure has Immediate and Persistent Effects on Cholinergic Systems: Critical Periods, Patterns of Exposure, Dose Thresholds FREE
Yael Abreu-Villaça, Frederic J Seidler, Dan Qiao, Charlotte A Tate, Mandy M Cousins, Indira Thillai and Theodore A Slotkin
Neuropsychopharmacology 28: 1935-1949; advance online publication, June 4, 2003; doi:10.1038/sj.npp.1300221
Variations in Maternal Care Alter GABAA Receptor Subunit Expression in Brain Regions Associated with Fear FREE
Christian Caldji, Josie Diorio and Michael J Meaney
Neuropsychopharmacology 28: 1950-1959; advance online publication, July 23, 2003; doi:10.1038/sj.npp.1300237
Intermittent Morphine Administration Induces Dependence and is a Chronic Stressor in Rats FREE
Hani Houshyar, Francisca Gomez, Sotara Manalo, Aditi Bhargava and Mary F Dallman
Neuropsychopharmacology 28: 1960-1972; advance online publication, August 13, 2003; doi:10.1038/sj.npp.1300271
Vivitrex®, an Injectable, Extended-Release Formulation of Naltrexone, Provides Pharmacokinetic and Pharmacodynamic Evidence of Efficacy for 1 Month in Rats FREE
Raymond T Bartus, Dwaine F Emerich, Joyce Hotz, Marc Blaustein, Reginald L Dean, Brigido Perdomo and Anthony S Basile
Neuropsychopharmacology 28: 1973-1982; advance online publication, August 20, 2003; doi:10.1038/sj.npp.1300274
The R7 Subfamily of RGS Proteins Assists Tachyphylaxis and Acute Tolerance at 
-Opioid Receptors FREE
Javier Garzón, Almudena López-Fando and Pilar Sánchez-Blázquez
Neuropsychopharmacology 28: 1983-1990; advance online publication, August 6, 2003; doi:10.1038/sj.npp.1300263
ABCB1 (MDR1)-Type P-Glycoproteins at the Blood–Brain Barrier Modulate the Activity of the Hypothalamic–Pituitary–Adrenocortical System: Implications for Affective Disorder FREE
Marianne B Müller, Martin E Keck, Elisabeth B Binder, Adelheid E Kresse, Thomas P Hagemeyer, Rainer Landgraf, Florian Holsboer and Manfred Uhr
Neuropsychopharmacology 28: 1991-1999; advance online publication, July 23, 2003; doi:10.1038/sj.npp.1300257
Effects of Buprenorphine Maintenance Dose on -Opioid Receptor Availability, Plasma Concentrations, and Antagonist Blockade in Heroin-Dependent Volunteers FREE
Mark K Greenwald, Chris-Ellyn Johanson, David E Moody, James H Woods, Michael R Kilbourn, Robert A Koeppe, Charles R Schuster and Jon-Kar Zubieta
Neuropsychopharmacology 28: 2000-2009; advance online publication, August 6, 2003; doi:10.1038/sj.npp.1300251
In vivo Measurement of the Serotonin Transporter with (S)-([18F]fluoromethyl)-(+)-McN5652 FREE
P Brust, R Hinz, H Kuwabara, S Hesse, J Zessin, B Pawelke, H Stephan, R Bergmann, J Steinbach and O Sabri
Neuropsychopharmacology 28: 2010-2019; advance online publication, August 20, 2003; doi:10.1038/sj.npp.1300281
Altered NMDA Glutamate Receptor Antagonist Response in Recovering Ethanol-Dependent Patients FREE
John H Krystal, Ismene L Petrakis, Diana Limoncelli, Elizabeth Webb, Ralitza Gueorgueva, D Cyril D'Souza, Nashaat N Boutros, Louis Trevisan and Dennis S Charney
Neuropsychopharmacology 28: 2020-2028; advance online publication, July 23, 2003; doi:10.1038/sj.npp.1300252
Neurocognitive Performance and Clinical Changes in Olanzapine-Treated Patients with Schizophrenia FREE
Raquel E Gur, Christian Kohler, J Daniel Ragland, Steven J Siegel, Warren B Bilker, James Loughead, Nick Phend and Ruben C Gur
Neuropsychopharmacology 28: 2029-2036; advance online publication, August 6, 2003; doi:10.1038/sj.npp.1300275
Subdissociative Dose Ketamine Produces a Deficit in Manipulation but not Maintenance of the Contents of Working Memory FREE
Rebekah A E Honey, Danielle C Turner, Garry D Honey, Sam R Sharar, D Kumaran, E Pomarol-Clotet, P McKenna, B J Sahakian, T W Robbins and P C Fletcher
Neuropsychopharmacology 28: 2037-2044; advance online publication, July 30, 2003; doi:10.1038/sj.npp.1300272
Complicated Case Study
Magnetic Seizure Therapy Improves Mood in Refractory Major Depression FREE
Markus Kosel, Caroline Frick, Sarah H Lisanby, Hans-Ulrich Fisch and Thomas E Schlaepfer
Neuropsychopharmacology 28: 2045-2048; advance online publication, August 27, 2003; doi:10.1038/sj.npp.1300293
Letters to the Editor
Effect of Divalproex Combined with Olanzapine or Risperidone in Patients with an Acute Exacerbation of Schizophrenia FREE
Maria B Isaac and Michael T Isaac
Neuropsychopharmacology 28: 2049; advance online publication, September 10, 2003; doi:10.1038/sj.npp.1300273
Valproate and GABAergic System Effects FREE
Georg Winterer
Neuropsychopharmacology 28: 2050-2051; advance online publication, May 22, 2003; doi:10.1038/sj.npp.1300245
Reply
Effect of Divalproex Combined with Olanzapine or Risperidone in Patients with an Acute Exacerbation of Schizophrenia FREE
Daniel E Casey, David G Daniel, Adel A Wassef, Latherine A Tracy, Patricia Wozniak and Kenneth W Sommerville For the Depakote psychosis group
Neuropsychopharmacology 28: 2052-2053; advance online publication, July 16, 2003; doi:10.1038/sj.npp.1300246
